Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0R3FS
|
|||
Former ID |
DIB020594
|
|||
Drug Name |
ODQ
|
|||
Synonyms |
1h-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one; 41443-28-1; ODQ; [1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one; UNII-S57V2NMV38; S57V2NMV38; 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one; ODQ, 98%; SR-01000075519; 1-H-[1,2,4]Oxadiazolo-[4,3,2]quinoxalin-1-ine; 1H-ODQ; Tocris-0880; AC1L1BIQ; Lopac-O-3636; AC1Q6H5T; Lopac0_000953; SCHEMBL210817; CHEMBL598952; GTPL5234; DTXSID2036796; CTK1D6485; CHEBI:91215; MolPort-003-959-081; HMS3649K18; HMS3262P08; HMS3266N10; KS-000013GE; ZINC2569341; BCP06748; Tox21_500953; GL1507; 1963AH; MFCD00792620; BS0137
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C9H5N3O2
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)N=CC3=NOC(=O)N23
|
|||
InChI |
1S/C9H5N3O2/c13-9-12-7-4-2-1-3-6(7)10-5-8(12)11-14-9/h1-5H
|
|||
InChIKey |
LZMHWZHOZLVYDL-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 41443-28-1
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
841953, 3153176, 5522201, 8151141, 11111575, 11113755, 12105926, 14717136, 14772849, 17405511, 24278054, 24439794, 26759284, 47440371, 50000344, 50104614, 50104615, 52175242, 53778059, 56311190, 56311195, 57320906, 85088400, 85231169, 85787574, 90341143, 91721861, 92304117, 103068904, 103085517, 103725947, 104297791, 117594658, 118696060, 121361752, 124750121, 124880986, 124880987, 125824947, 126671518, 126736393, 128563658, 137039585, 142472740, 143856525, 144107870, 160871480, 162022700, 162092542, 162529374
|
|||
ChEBI ID |
CHEBI:91215
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Soluble guanylyl cyclase (GUCY2D) | Target Info | Inhibitor | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5234). | |||
REF 2 | Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol. 1995 Aug;48(2):184-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.